Tags

Type your tag names separated by a space and hit enter

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Abstract

In a population-based study in southern Wisconsin, 1,370 patients given diagnoses of diabetes at age 30 years or older were examined using standard protocols to determine the prevalence and severity of diabetic retinopathy and associated risk variables. The prevalence of diabetic retinopathy varied from 28.8% in persons who had diabetes for less than five years to 77.8% in persons who had diabetes for 15 or more years. The rate of proliferative diabetic retinopathy varied from 2.0% in persons who had diabetes for less than five years to 15.5% in persons who had diabetes for 15 or more years. By using the Cox regression model, the severity of retinopathy was found to be related to longer duration of diabetes, younger age at diagnosis, higher glycosylated hemoglobin levels, higher systolic BP, use of insulin, presence of proteinuria, and small body mass.

Links

  • Publisher Full Text
  • Authors

    , , , ,

    Source

    MeSH

    Aged
    Blood Pressure
    Body Weight
    Diabetes Mellitus
    Diabetic Retinopathy
    Epidemiologic Methods
    Female
    Glycated Hemoglobin A
    Humans
    Insulin
    Male
    Middle Aged
    Risk
    Sex
    Time Factors
    Wisconsin

    Pub Type(s)

    Journal Article
    Research Support, U.S. Gov't, P.H.S.

    Language

    eng

    PubMed ID

    6367725

    Citation

    Klein, R, et al. "The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and Risk of Diabetic Retinopathy when Age at Diagnosis Is 30 or More Years." Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 102, no. 4, 1984, pp. 527-32.
    Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-32.
    Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology (Chicago, Ill. : 1960), 102(4), pp. 527-32.
    Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and Risk of Diabetic Retinopathy when Age at Diagnosis Is 30 or More Years. Arch Ophthalmol. 1984;102(4):527-32. PubMed PMID: 6367725.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. AU - Klein,R, AU - Klein,B E, AU - Moss,S E, AU - Davis,M D, AU - DeMets,D L, PY - 1984/4/1/pubmed PY - 1984/4/1/medline PY - 1984/4/1/entrez SP - 527 EP - 32 JF - Archives of ophthalmology (Chicago, Ill. : 1960) JO - Arch. Ophthalmol. VL - 102 IS - 4 N2 - In a population-based study in southern Wisconsin, 1,370 patients given diagnoses of diabetes at age 30 years or older were examined using standard protocols to determine the prevalence and severity of diabetic retinopathy and associated risk variables. The prevalence of diabetic retinopathy varied from 28.8% in persons who had diabetes for less than five years to 77.8% in persons who had diabetes for 15 or more years. The rate of proliferative diabetic retinopathy varied from 2.0% in persons who had diabetes for less than five years to 15.5% in persons who had diabetes for 15 or more years. By using the Cox regression model, the severity of retinopathy was found to be related to longer duration of diabetes, younger age at diagnosis, higher glycosylated hemoglobin levels, higher systolic BP, use of insulin, presence of proteinuria, and small body mass. SN - 0003-9950 UR - https://www.unboundmedicine.com/medline/citation/6367725/full_citation L2 - https://jamanetwork.com/journals/jamaophthalmology/fullarticle/vol/102/pg/527 DB - PRIME DP - Unbound Medicine ER -